Production Cost Report
tanespimycin-e11a
magnesium-sulfate-e11a,riboflavin-e11a,paracetamol-e11a
Tanespimycin
Tanespimycin is an inhibitor of a heat shock protein that plays a central role in promoting the functionality and stability of a group of proteins associated with cancer. Tanespimycin is a derivative of geldanamycin, an antibiotic that is being studied in the treatment of cancer and patients with certain types of leukemia or tumors.

Tanespimycin Production Cost Reports - 2019/20

Capital Investment & Operating Cost of Tanespimycin Plants

Tanespimycin is an inhibitor of a heat shock protein that plays a central role in promoting the functionality and stability of a group of proteins associated with cancer. Tanespimycin is a derivative of geldanamycin, an antibiotic that is being studied in the treatment of cancer and patients with certain types of leukemia or tumors.

Intratec offers professional, easy-to-understand reports examining Tanespimycin production. Each study describes an industrial plant, including main process units and site infrastructure, and presents an independent analysis of capital and operating costs. All reports are based on the most recent economic data available (2019/20).

Tanespimycin Production from Corn - Cost Analysis | Tanespimycin E11A
This report presents the economics of the production of Tanespimycin production from corn in the USA, via a typical fermentation process.

Analysis Basis: USA   |   2019 Q1   |   101 pages   Starting at $1,999

Customers Who Bought This Report Also Bought

Magnesium Sulfate Production Process - Cost Analysis | Magnesium Sulfate E11A
This report analyses the economics of a Magnesium Sulfate production process from magnesium carbonate and sulfuric acid in the USA.

Analysis Basis: USA | 2019 Q1 | 101 pages Starting at $1,099

Paracetamol Production from p-Nitrochlorobenzene - Cost Analysis | Paracetamol E11A
This report analyses the economics of Paracetamol production from 4-nitrochlorobenzene, sodium hydroxide, hydrogen and acetic anhydride in the USA.

Analysis Basis: USA | 2019 Q1 | 99 pages Starting at $1,999

Riboflavin Production from Glucose - Cost Analysis | Riboflavin E11A
This report presents the economics of Riboflavin production from glucose in the USA, via a typical fermentation process.

Analysis Basis: USA | 2019 Q1 | 101 pages Starting at $1,999

Use our Reports as

Feasibility Studies

Techno-economic Evaluations

Investment Analyses

Multi-regional Cost Analyses

Trusted By

BASF
Monsanto
Linde